Clinical trials
Phase 1 Neuroinflammatory Diseases trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
18 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 3 |
| 2009 | 1 |
| 2016 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 2 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 7 |
| Not yet recruiting | 4 |
| Recruiting | 3 |
| Terminated | 2 |
| Active, not recruiting | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Institute of Mental Health (NIMH) | 4 |
| Bayer | 2 |
| Beijing Tiantan Hospital | 1 |
| Biomed Industries, Inc. | 1 |
| Christopher John McDougle, M.D. | 1 |
| Contineum Therapeutics | 1 |
| Icahn School of Medicine at Mount Sinai | 1 |
| Jennifer Mitchell | 1 |
| Liu Qing | 1 |
| Monument Therapeutics Limited | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neuroinflammatory Diseases | 18 |
| Cognitive Dysfunction | 3 |
| Multiple Sclerosis | 3 |
| Alzheimer Disease | 2 |
| Amyotrophic Lateral Sclerosis | 2 |
| Autoimmune Diseases | 2 |
| Dementia | 2 |
| Epilepsy | 2 |
| Neurocysticercosis | 2 |
| Taeniasis | 2 |
Trials
Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.